[{"id":"6a490e62-86df-4fc9-a3fe-fddb8498805a","acronym":"","url":"https://clinicaltrials.gov/study/NCT03084926","created_at":"2021-01-18T15:11:49.873Z","updated_at":"2024-07-02T16:36:18.747Z","phase":"Phase 1","brief_title":"First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors","source_id_and_acronym":"NCT03084926","lead_sponsor":"Molecular Partners AG","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MP0274"],"overall_status":"Completed","enrollment":" Enrollment 22","initiation":"Initiation: 08/08/2017","start_date":" 08/08/2017","primary_txt":" Primary completion: 12/13/2021","primary_completion_date":" 12/13/2021","study_txt":" Completion: 12/13/2021","study_completion_date":" 12/13/2021","last_update_posted":"2022-01-10"}]